ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,844.47
1.37%
S&P 500
5,459.10
1.11%
Dow Jones
40,589.34
1.64%
US Dollar vs Yen
153.745
0.00%
Brent Oil
79.745
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. AMEX
  6. Armata Pharmaceuticals Inc (ARMP)

  7. Armata Pharmaceuticals Inc (ARMP) ニュース

ARMP

Armata Pharmaceuticals (ARMP)

Armata Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:ARMP
日付受信時刻ニュースソース見出しコード企業名
2024/07/2605 : 15Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
2024/06/1505 : 09Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
2024/05/0805 : 25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
2024/05/0805 : 15Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
2024/03/0507 : 35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
2024/03/0506 : 03Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
2024/01/2406 : 17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ARMPArmata Pharmaceuticals Inc
2023/12/2711 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/12/2711 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/12/2711 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/12/2711 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/12/2711 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/12/2711 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/12/2711 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/12/2711 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/11/1607 : 24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ARMPArmata Pharmaceuticals Inc
2023/09/2308 : 17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/09/2021 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
2023/08/1420 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
2023/08/1420 : 15Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
2023/08/0405 : 37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:ARMPArmata Pharmaceuticals Inc
2023/08/0405 : 35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:ARMPArmata Pharmaceuticals Inc
2023/08/0405 : 34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
2023/07/2505 : 30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
2023/07/2005 : 30Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
2023/07/1922 : 56Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
2023/07/1121 : 27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
2023/07/1121 : 15Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
2023/06/2805 : 31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ARMPArmata Pharmaceuticals Inc
2023/05/1219 : 03Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ARMPArmata Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:ARMP

最近閲覧した銘柄

NASDAQ
FJNYIX
Diversified High Income ...
NASDAQ
ABHHTXX
Royal Bank of Canada Itm...
BOV
CATP34Q
Caterpillar
NASDAQ
ZCFCJX
Revo Capital Fund Iii
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有